CJ Bioscience, Inc. (KOSDAQ:311690)
5,610.00
-290.00 (-4.92%)
At close: May 27, 2026
-42.46% (1Y)
| Market Cap | 73.56B -45.1% |
| Revenue (ttm) | 3.69B +6.5% |
| Net Income | -24.00B |
| EPS | -1,837.29 |
| Shares Out | 13.07M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 65,848 |
| Open | 5,900.00 |
| Previous Close | 5,900.00 |
| Day's Range | 5,530.00 - 5,900.00 |
| 52-Week Range | 5,530.00 - 12,300.00 |
| Beta | 0.41 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 28, 2026 |